A detailed history of Israel Englander (Millennium Management LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Millennium Management LLC holds 70,100 shares of ZTS stock, worth $12.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
70,100
Previous 93,600 25.11%
Holding current value
$12.3 Million
Previous $16.2 Million 15.59%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $49.2 Million - $56.1 Million
-285,274 Reduced 71.69%
112,652 $22 Million
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $67.7 Million - $83.2 Million
-465,484 Reduced 53.91%
397,926 $69 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $126 Million - $152 Million
759,084 Added 727.61%
863,410 $146 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $27.6 Million - $36.4 Million
-182,060 Reduced 63.57%
104,326 $20.6 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $23.1 Million - $26.8 Million
-143,645 Reduced 33.4%
286,386 $49.3 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $76.7 Million - $92.3 Million
-527,380 Reduced 55.08%
430,031 $71.6 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $45.9 Million - $55.1 Million
349,780 Added 57.56%
957,411 $140 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $10.3 Million - $12.7 Million
69,467 Added 12.91%
607,631 $90.1 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $32.4 Million - $41.6 Million
-207,758 Reduced 27.85%
538,164 $92.5 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $125 Million - $161 Million
688,569 Added 1200.58%
745,922 $141 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $71.9 Million - $91.7 Million
-371,361 Reduced 86.62%
57,353 $14 Million
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $19.7 Million - $21.8 Million
-104,137 Reduced 19.54%
428,714 $83.2 Million
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $88.9 Million - $107 Million
-570,461 Reduced 51.7%
532,851 $99.3 Million
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $133 Million - $157 Million
926,998 Added 525.77%
1,103,312 $174 Million
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $26.3 Million - $29.2 Million
-167,573 Reduced 48.73%
176,314 $29.2 Million
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $13.1 Million - $15.8 Million
-95,497 Reduced 21.73%
343,887 $56.9 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $33.2 Million - $42.3 Million
296,842 Added 208.25%
439,384 $60.2 Million
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $21.1 Million - $33 Million
-228,001 Reduced 61.53%
142,542 $16.8 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $115 Million - $132 Million
-993,397 Reduced 72.83%
370,543 $49 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $2.18 Million - $2.49 Million
19,410 Added 1.44%
1,363,940 $170 Million
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $12.6 Million - $14.7 Million
-128,629 Reduced 8.73%
1,344,530 $153 Million
Q1 2019

May 14, 2019

BUY
$81.56 - $100.67 $119 Million - $147 Million
1,458,780 Added 10145.21%
1,473,159 $148 Million
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $80.4 Million - $96.6 Million
-1,013,952 Reduced 98.6%
14,379 $1.23 Million
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $38.6 Million - $43.1 Million
462,733 Added 81.81%
1,028,331 $94.2 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $130 Million - $145 Million
-1,629,180 Reduced 74.23%
565,598 $48.2 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $15 Million - $17.8 Million
210,308 Added 10.6%
2,194,778 $183 Million
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $84.8 Million - $97.6 Million
1,340,378 Added 208.1%
1,984,470 $143 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $38.5 Million - $42.1 Million
644,092
644,092 $41.1 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.